42
Participants
Start Date
July 17, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
April 30, 2030
LUCAR-G79 T cells
Prior to infusion of the LUCAR-G79 T cells, subjects will receive a conditioning premedication regimen consisting of cyclophosphamide and fludarabine.
RECRUITING
The Third The People's Hospital of Bengbu, Bengbu
NOT_YET_RECRUITING
Affiliated Hospital of Nantong University, Nantong
NOT_YET_RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
NOT_YET_RECRUITING
Shanghai Zhongshan Hospital, Shanghai
NOT_YET_RECRUITING
The second Affiliated Hospital of Xi'an Jiaotong University, Xi’an
Lead Sponsor
Nanjing Legend Biotech Co.
INDUSTRY